Literature DB >> 14570313

Pharmaceutical applications of shellac: moisture-protective and taste-masking coatings and extended-release matrix tablets.

N Pearnchob1, J Siepmann, R Bodmeier.   

Abstract

Shellac is a natural polymer, which is used as enteric coating material in pharmaceutical applications. The major objective of the present study was to investigate the potential of shellac for other purposes, namely to provide moisture-protective and taste-masking coatings as well as extended-release matrix tablets. The efficiency of shellac to achieve moisture protection and taste masking was compared with that of hydroxypropyl methylcellulose (HPMC), which is most frequently used for these purposes. Shellac-coated tablets showed lower water uptake rates than HPMC-coated systems at the same coating level. The stability of acetylsalicylic acid was higher in tablets coated with shellac compared with HPMC-coated systems, irrespective of the storage humidity. Therefore, lower shellac coating levels were required to achieve the same degree of drug protection. Shellac coatings effectively masked the unpleasant taste of acetaminophen tablets. Compared to HPMC, again lower coating levels were required to achieve similar effects. The resulting drug release in simulated gastric fluid was not significantly altered by the thin shellac coatings, which rapidly ruptured due to the swelling of the coated tablet core. In addition, shellac was found to be a suitable matrix former for extended-release tablets. The latter could be prepared by direct compression or via wet granulation using ethanolic or ammoniated aqueous shellac binder solutions. The resulting drug-release patterns could effectively be altered by varying different formulation and processing parameters.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14570313     DOI: 10.1081/ddc-120024188

Source DB:  PubMed          Journal:  Drug Dev Ind Pharm        ISSN: 0363-9045            Impact factor:   3.225


  8 in total

1.  Optimization of process parameters for a quasi-continuous tablet coating system using design of experiments.

Authors:  Christine Cahyadi; Paul Wan Sia Heng; Lai Wah Chan
Journal:  AAPS PharmSciTech       Date:  2010-12-23       Impact factor: 3.246

2.  Salt Engineering of Aripiprazole with Polycarboxylic Acids to Improve Physicochemical Properties.

Authors:  Hamideh Afrooz; Eman M Mohamed; Sogra F Barakh Ali; Sathish Dharani; Mohammad T H Nutan; Mansoor A Khan; Ziyaur Rahman
Journal:  AAPS PharmSciTech       Date:  2021-01-06       Impact factor: 3.246

3.  Introducing natural thermoplastic shellac to microfluidics: A green fabrication method for point-of-care devices.

Authors:  R Lausecker; V Badilita; U Gleißner; U Wallrabe
Journal:  Biomicrofluidics       Date:  2016-07-05       Impact factor: 2.800

4.  An Advanced Formulation of a Magnesium Dietary Supplement Adapted for a Long-Term Use Supplementation Improves Magnesium Bioavailability: In Vitro and Clinical Comparative Studies.

Authors:  Christian Dualé; Jean-Michel Cardot; Fabienne Joanny; Anna Trzeciakiewicz; Elodie Martin; Gisèle Pickering; Claude Dubray
Journal:  Biol Trace Elem Res       Date:  2018-03-09       Impact factor: 3.738

5.  Formulation and Development of Aqueous Film Coating for Moisture Protection of Hygroscopic Herniaria glabra L. Tablets

Authors:  Hakim El Mabrouki; Irina Evgenievna Kaukhova
Journal:  Turk J Pharm Sci       Date:  2022-04-29

6.  The Development of a Melt-Extruded Shellac Carrier for the Targeted Delivery of Probiotics to the Colon.

Authors:  Noel M Gately; James E Kennedy
Journal:  Pharmaceutics       Date:  2017-09-22       Impact factor: 6.321

Review 7.  An Update of Moisture Barrier Coating for Drug Delivery.

Authors:  Qingliang Yang; Feng Yuan; Lei Xu; Qinying Yan; Yan Yang; Danjun Wu; Fangyuan Guo; Gensheng Yang
Journal:  Pharmaceutics       Date:  2019-09-01       Impact factor: 6.321

Review 8.  Sustainable Natural Bio-Origin Materials for Future Flexible Devices.

Authors:  Lingyi Lan; Jianfeng Ping; Jiaqing Xiong; Yibin Ying
Journal:  Adv Sci (Weinh)       Date:  2022-03-24       Impact factor: 17.521

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.